NTRB - NutriBand Inc.

QQQ $ 622.49 $ 0.90 (0.15 %)

DIA $ 479.63 $ 5.34 (1.13 %)

SPY $ 683.37 $ 2.90 (0.43 %)

TLT $ 89.91 $ 0.01 (0.01 %)

GLD $ 380.58 $ -0.09 (-0.02 %)

Previous Close

$ 6.09

Open

$ 5.94

Bid

$ 5.50 x 12

Ask

$ 6.20 x 2

Day's Range

-- - --

52 Week Range

$ 3.72 - $ 11.78

Volume

11,453

Average Volume

Market Cap

67.93M

Beta (5Y Monthly)

$ 1.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	09-09-2025	07-31-2025	10-Q
2	05-30-2025	04-30-2025	10-Q
3	04-28-2025	01-31-2025	10-K
4	12-04-2024	10-31-2024	10-Q
5	09-03-2024	07-31-2024	10-Q
6	05-31-2024	04-30-2024	10-Q
7	04-30-2024	01-31-2024	10-K
8	12-13-2023	10-31-2023	10-Q
9	09-08-2023	01-01-1970	10-Q
10	06-09-2023	04-30-2023	10-Q
11	04-26-2023	01-31-2023	10-K
12	12-02-2022	10-31-2022	10-Q
13	09-07-2022	07-31-2022	10-Q
14	05-31-2022	04-30-2022	10-Q
15	04-28-2022	01-31-2022	10-K
16	12-14-2021	10-31-2021	10-Q
17	09-03-2021	07-31-2021	10-Q
18	06-14-2021	04-30-2021	10-Q
19	04-02-2021	01-31-2021	10-K
20	12-15-2020	10-31-2020	10-Q
21	09-11-2020	07-31-2020	10-Q
22	06-04-2020	04-30-2020	10-Q
23	04-14-2020	01-31-2020	10-K
24	12-12-2019	10-31-2019	10-Q
25	09-13-2019	07-31-2019	10-Q
26	06-13-2019	04-30-2019	10-Q
27	04-19-2019	01-31-2019	10-K
28	12-14-2018	10-31-2018	10-Q
29	09-17-2018	07-31-2018	10-Q
30	06-18-2018	04-30-2018	10-Q
31	05-01-2018	01-31-2018	10-K
32	12-08-2017	10-31-2017	10-Q
33	09-19-2017	07-31-2017	10-Q
34	06-19-2017	04-30-2017	10-Q
35	05-08-2017	01-31-2017	10-K
36	12-13-2016	10-31-2016	10-Q
37	09-14-2016	07-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Tuesday's ...
10/28/2025 12:10:21

Nutriband Founder Gareth Sheridan Returns ...
10/27/2025 11:09:05

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company founder, Gareth Sheridan has returned as Company CEO. Du...

Nutriband Signs Agreement Brand Institute ...
10/10/2025 11:05:24

Nutriband initiates commercial worldwide brand name development for its lead product, an abuse deterrent transdermal system.Nut...

Nutriband Files Provisional Patent Applica...
10/08/2025 12:43:57

Nutriband Q2 Adj. EPS $(0.18) Misses $(0.1...
09/10/2025 14:05:24

Nutriband (NASDAQ:NTRB) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.17) b...

Nutriband Reports 50.87% Revenue Growth, $...
09/10/2025 13:20:55

Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the six months ended July 31, 2025. The company ...

Nutriband CEO Gareth Sheridan Steps Aside ...
08/11/2025 09:07:07

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company CEO, Gareth Sheridan will be stepping aside from his role...

12 Health Care Stocks Moving In Friday's P...
08/08/2025 12:08:44

Nutriband Granted Meeting Request By FDA F...
08/08/2025 12:04:26

Nutriband To Issue 25% Preferred Stock Div...
07/18/2025 13:37:26

Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") is today reminding shareholders of t...

12 Health Care Stocks Moving In Wednesday'...
07/02/2025 17:05:51

Nutriband Board Approves 25% Preferred Sto...
07/02/2025 12:06:38

Nutriband Completes Commercial Manufacturi...
06/18/2025 11:01:43

Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-...

Nutriband Says Patent Issuance Expands US ...
06/09/2025 11:33:04

Patent issuance expands United States patent coverage for AVERSA™ transdermal abuse deterrent technologyAVERSA™ transdermal abu...

Nutriband Q1 EPS $(0.12) Beats $(0.20) Est...
06/02/2025 12:19:42

Nutriband (NASDAQ:NTRB) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.20) by ...

Nutriband Quarterly Reports Revenue For Q1...
06/02/2025 12:06:58

Progress continues on the development of AVERSA Fentanyl, with the Company formalizing an exclusive product development partner...

12 Health Care Stocks Moving In Wednesday'...
04/30/2025 17:05:40

Earlier Reported: Nutriband CEO Said AVERS...
04/30/2025 16:32:33

AVERSA Fentanyl has the potential to become the world's first opioid pain patch with abuse deterrent properties and is esti...

Nutriband Secures Macao Patent for AVERSA,...
04/11/2025 11:03:20

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical pro...

Nutriband Inc. Signs Associate Partnership...
04/04/2025 11:11:07